Vijetha Bhat is a technology expert working within licensing at Lonza Specialized Modalities. Vijetha started her scientific career at Lonza in 2017 and has since contributed to a variety of projects focusing on developing production platforms and analytics for viral vectors in the cell and gene therapy space. Leveraging over 15 years of experience in the biopharma industry, she provides in-depth technical direction to users working with Lonza’s expression platforms. Prior to joining Lonza, Vijetha worked at Nanospectra Biosciences, an early-stage medical device company, developing nanotechnology-based therapies for oncology applications. She has a background in biotechnology from India and holds a master’s degree in Bioengineering from Rice University.